Virtu Financial LLC Karuna Therapeutics, Inc. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$161.01 - $317.85 $2.1 Million - $4.16 Million	13,073 New	13,073 $4.14 Million
Q2 2023 Jul 27, 2023	SELL	$176.32 - $240.22 $625,936 - $852,781	-3,550 Reduced 60.48%	2,320 $503,000
Q1 2023 May 01, 2023	BUY	$161.33 - $204.36 $768,737 - $973,775	4,765 Added 431.22%	5,870 $1.07 Million
Q4 2022 Feb 15, 2023	SELL	$191.53 - $236.82 $601,978 - $744,325	-3,143 Reduced 73.99%	1,105 $217,000
Q3 2022 Nov 07, 2022	BUY	$123.79 - $277.42 $525,859 - $1.18 Million	4,248 New	4,248 $955,000
Q3 2021 Nov 12, 2021	SELL	$101.2 - $125.87 $412,997 - $513,675	-4,081 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$107.45 - $135.95 $438,503 - $554,811	4,081 New	4,081 $465,000
Q3 2020 Dec 11, 2020	SELL	$71.31 - $109.74 $340,505 - $524,008	-4,775 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$62.14 - $117.21 $5,530 - $10,431	89 Added 1.9%	4,775 $532,000
Q4 2019 Feb 04, 2020	BUY	$11.44 - $123.99 $53,607 - $581,017	4,686 New	4,686 $353,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.